Zomig Side Effects
Generic name: zolmitriptan
Note: This document provides detailed information about Zomig Side Effects associated with zolmitriptan. Some dosage forms listed on this page may not apply specifically to the brand name Zomig.
Applies to zolmitriptan: oral tablet, oral tablet disintegrating.
Other dosage forms:
Serious side effects of Zomig
Along with its needed effects, zolmitriptan (the active ingredient contained in Zomig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking zolmitriptan:
More common side effects
- chest pain (severe)
- heaviness, tightness, or pressure in the chest or neck
- sensation of burning, warmth, heat, numbness, tightness, or tingling
Less common or rare side effects
- abdominal or stomach pain (severe)
- changes in facial skin color
- cough or hoarseness
- diarrhea
- fast or irregular heartbeat
- fever or chills
- hives, itching, or skin rash
- itching
- loss of appetite
- lower back or side pain
- nausea
- painful or difficult urination
- puffiness or swelling of the eyelids or around the eyes, face, or lips
- tightness in the chest
- trouble breathing
- weakness
Rare side effects
- blurred vision
- confusion
- difficulty swallowing
- dizziness
- fainting
- frequent strong or increased urge to urinate
- headache
- increased volume of pale, dilute urine
- nervousness
- pounding in the ears
- severe numbness, especially on one side of the face or body
- slow heartbeat
- unusual tiredness or weakness
Incidence not known
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
Other side effects of Zomig
Some side effects of zolmitriptan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- lack or loss of strength
- sleepiness or unusual drowsiness
- warm or cold sensation
Less common side effects
- dizziness or lightheadedness
- dry mouth
- feeling of constant movement of self or surroundings
- sensation of spinning
Rare side effects
- anxiety
- crying
- depersonalization
- depression
- dysphoria
- euphoria
- hyperventilation
- irritability
- loss of memory
- paranoia
- problems with memory
- quick to react or overreact emotionally
- rapidly changing moods
- redness of the skin
- seeing, hearing, or feeling things that are not there
- shaking
- trouble sleeping
- welts
For healthcare professionals
Applies to zolmitriptan: nasal spray, oral tablet, oral tablet disintegrating.
General adverse events
The most common adverse reactions included neck, throat, jaw pain; dizziness; paresthesia; asthenia; somnolence; warm and cold sensation; nausea; heaviness sensation; and dry mouth. In adolescents treated with the nasal spray, the more commonly reported adverse reactions included dysgeusia, nasal discomfort, dizziness, oropharyngeal pain, and nausea.[Ref]
Nervous system
- Very common (greater than 10%): Taste disturbances (up to 21%, inhaler)
- Common (1% to 10%): Paresthesia, somnolence, dizziness, hyperesthesia
- Rare (less than 0.1%): Cerebral ischemia, amnesia, convulsions, ataxia, dystonia, hyperkinesia, hypotonia, hypertonia
- Frequency not reported: Serotonin syndrome[Ref]
Paresthesia appears to be a dose-related adverse event occurring in 5%, 7%, and 9% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.[Ref]
Other
- Common (1% to 10%): Warm/cold sensation, heaviness other than chest or neck, pressure/tightness/heaviness, vertigo, asthenia, chills
- Uncommon (0.1% to 1%): Tinnitus, hyperacusis, ear pain[Ref]
Gastrointestinal
- Common (1% to 10%): Nausea, dry mouth, dysphagia, dyspepsia, abdominal pain, vomiting
- Uncommon (0.1% to 1%): Gastroenteritis, increased thirst
- Rare (less than 0.1%): Stomatitis, constipation, hematemesis, pancreatitis, melena, ulcer
- Very rare (less than 0.01%): Bloody diarrhea, gastrointestinal infarction or necrosis, gastrointestinal ischemic events, ischemic colitis, splenic infarction[Ref]
Cardiovascular
- Common (1% to 10%): Chest pain/tightness/pressure and/or heaviness, neck/throat/jaw pain/tightness/pressure, palpitations
- Uncommon (0.1% to 1%): Arrhythmias, hypertension, syncope, tachycardia
- Rare (less than 0.1%): Angina pectoris, myocardial infarct, coronary vasospasm, QT prolongation, thrombophlebitis[Ref]
Rare reports of serious cardiac adverse events have been reported including acute myocardial infarction within a few hours following administration of this drug.
Chest pain/tightness/pressure and/or heaviness appear to be dose-related occurring in 2%, 3%, and 4% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively. Neck/throat/jaw pain/tightness/pressure occurred in 4%, 7%, and 10% of patients, respectively.[Ref]
Hematologic
- Uncommon (0.1% to 1%): ecchymosis
- Rare (less than 0.1%): Thrombocytopenia, eosinophilia, leucopenia[Ref]
Metabolic
- Uncommon (0.1% to 1%): Increased appetite, thirst
- Rare (less than 0.1%): Anorexia, hyperglycemia[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia, myalgia, muscle weakness
- Uncommon (0.1% to 1%): Back pain, leg cramps, tenosynovitis
- Rare (less than 0.1%): Arthritis, tetanus, twitching[Ref]
Respiratory
- Common (1% to 10%): Disorder/discomfort of nasal cavity, throat pain, throat tightness, oropharyngeal pain
- Uncommon (0.1% to 1%): Pharyngitis, rhinitis, dyspnea, sinusitis, bronchitis, increased cough, epistaxis, laryngeal edema, hiccup, laryngitis, yawn
- Rare (less than 0.1%): Apnea, voice alteration[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Allergic reactions
- Postmarketing reports: Hypersensitivity reactions including angioedema, anaphylactic reactions and anaphylactic shock[Ref]
Ocular
- Rare (less than 0.1%): Diplopia, dry eyes, lacrimation, conjunctivitis, eye pain, visual field defect[Ref]
Genitourinary
- Uncommon (0.1% to 1%): Polyuria, urinary urgency, cystitis, hematuria
- Rare (less than 0.1%): Urinary frequency, miscarriage, dysmenorrhea[Ref]
Dermatologic
- Common (1% to 10%): Sweating, facial edema
- Uncommon (0.1% to 1%): Urticaria, pruritus, rash, photosensitivity reaction
- Rare (less than 0.1%): Angioedema[Ref]
Local
- Common (1% to 10%): Local irritation or soreness at the site of administration of nasal spray
In clinical trials using the nasal spray approximately 3% (n=460) patients reported local irritation or soreness at the site of administration. Effects were severe in about 1% of patients and approximately 57% resolved in 1 hour. Nasopharyngeal examinations of a subset of patients failed to demonstrate any clinically significant changes with repeated use of the nasal spray.
References
1. (2001) "Product Information. Zomig (zolmitriptan)." Astra-Zeneca Pharmaceuticals
2. Alonso-Navarro H, Jimenez-Jimenez FJ (2005) "Myalgia and Cramps Associated With Zolmitriptan." Clin Neuropharmacol, 28, p. 241-242
Frequently asked questions
More about Zomig (zolmitriptan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (96)
- Drug images
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antimigraine agents
- Breastfeeding
Patient resources
- Zomig drug information
- Zomig nasal
- Zomig (Zolmitriptan Nasal) (Advanced Reading)
- Zomig (Zolmitriptan Oral) (Advanced Reading)
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Zomig side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.